Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
Abhijeet Singh, 1 Rajendra Prasad, 1, 2 Viswesvaran Balasubramanian, 1 Nikhil Gupta 3 1Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, Delhi 110007, India; 2Department of Pulmonary Medicine, King George Medical University, Lucknow, Uttar Pradesh...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/508928892d8c4092b241fec48e3debad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:508928892d8c4092b241fec48e3debad |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:508928892d8c4092b241fec48e3debad2021-12-02T09:50:59ZDrug-Resistant Tuberculosis and HIV Infection: Current Perspectives1179-1373https://doaj.org/article/508928892d8c4092b241fec48e3debad2020-01-01T00:00:00Zhttps://www.dovepress.com/drug-resistant-tuberculosis-and-hiv-infection-current-perspectives-peer-reviewed-article-HIVhttps://doaj.org/toc/1179-1373Abhijeet Singh, 1 Rajendra Prasad, 1, 2 Viswesvaran Balasubramanian, 1 Nikhil Gupta 3 1Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, Delhi 110007, India; 2Department of Pulmonary Medicine, King George Medical University, Lucknow, Uttar Pradesh 226003, India; 3Department of Internal Medicine, Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh 226010, IndiaCorrespondence: Rajendra PrasadDepartment of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, Delhi 110007, IndiaTel +91 9415 021 590Email rprasaddirvpci@gmail.comAbstract: Drug-resistant tuberculosis (DR-TB), including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), is considered a potential obstacle for elimination of TB globally. HIV coinfection with M/XDR-TB further complicates the scenario, and is a potential threat with challenging management. Reports have shown poor outcomes and alarmingly high mortality rates among people living with HIV (PLHIV) coinfected with M/XDR-TB. This coinfection is also responsible for all forms of M/XDR-TB epidemics or outbreaks. Better outcomes with reductions in mortality have been reported with concomitant treatment containing antiretroviral drugs for the HIV component and antitubercular drugs for the DR-TB component. Early and rapid diagnosis with genotypic tests, prompt treatment with appropriate regimens based on drug-susceptibility testing, preference for shorter regimens fortified with newer drugs, a patient-centric approach, and strong infection-control measures are all essential components in the management of M/XDR-TB in people living with HIV.Keywords: drug-resistant, HIV, multidrug-resistant, extensively drug-resistant, tuberculosisSingh APrasad RBalasubramanian VGupta NDove Medical Pressarticledrug resistanthivmultidrug resistantextensively drug resistanttuberculosisImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol Volume 12, Pp 9-31 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
drug resistant hiv multidrug resistant extensively drug resistant tuberculosis Immunologic diseases. Allergy RC581-607 |
spellingShingle |
drug resistant hiv multidrug resistant extensively drug resistant tuberculosis Immunologic diseases. Allergy RC581-607 Singh A Prasad R Balasubramanian V Gupta N Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives |
description |
Abhijeet Singh, 1 Rajendra Prasad, 1, 2 Viswesvaran Balasubramanian, 1 Nikhil Gupta 3 1Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, Delhi 110007, India; 2Department of Pulmonary Medicine, King George Medical University, Lucknow, Uttar Pradesh 226003, India; 3Department of Internal Medicine, Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh 226010, IndiaCorrespondence: Rajendra PrasadDepartment of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, Delhi 110007, IndiaTel +91 9415 021 590Email rprasaddirvpci@gmail.comAbstract: Drug-resistant tuberculosis (DR-TB), including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), is considered a potential obstacle for elimination of TB globally. HIV coinfection with M/XDR-TB further complicates the scenario, and is a potential threat with challenging management. Reports have shown poor outcomes and alarmingly high mortality rates among people living with HIV (PLHIV) coinfected with M/XDR-TB. This coinfection is also responsible for all forms of M/XDR-TB epidemics or outbreaks. Better outcomes with reductions in mortality have been reported with concomitant treatment containing antiretroviral drugs for the HIV component and antitubercular drugs for the DR-TB component. Early and rapid diagnosis with genotypic tests, prompt treatment with appropriate regimens based on drug-susceptibility testing, preference for shorter regimens fortified with newer drugs, a patient-centric approach, and strong infection-control measures are all essential components in the management of M/XDR-TB in people living with HIV.Keywords: drug-resistant, HIV, multidrug-resistant, extensively drug-resistant, tuberculosis |
format |
article |
author |
Singh A Prasad R Balasubramanian V Gupta N |
author_facet |
Singh A Prasad R Balasubramanian V Gupta N |
author_sort |
Singh A |
title |
Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives |
title_short |
Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives |
title_full |
Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives |
title_fullStr |
Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives |
title_full_unstemmed |
Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives |
title_sort |
drug-resistant tuberculosis and hiv infection: current perspectives |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/508928892d8c4092b241fec48e3debad |
work_keys_str_mv |
AT singha drugresistanttuberculosisandhivinfectioncurrentperspectives AT prasadr drugresistanttuberculosisandhivinfectioncurrentperspectives AT balasubramanianv drugresistanttuberculosisandhivinfectioncurrentperspectives AT guptan drugresistanttuberculosisandhivinfectioncurrentperspectives |
_version_ |
1718398002876383232 |